Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study

被引：752

作者：

Arnold, Melina ^{[1
]}

Rutherford, Mark J. ^{[1
,2
]}

Bardot, Aude ^{[1
]}

Ferlay, Jacques ^{[1
]}

Andersson, Therese M-L ^{[3
]}

Myklebust, Tor Age ^{[4
,5
]}

Tervonen, Hanna ^{[6
]}

Thursfield, Vicky ^{[7
]}

Ransom, David ^{[8
]}

Shack, Lorraine ^{[9
]}

Woods, Ryan R. ^{[10
]}

Turner, Donna ^{[11
]}

Leonfellner, Suzanne ^{[13
]}

Ryan, Susan ^{[12
]}

Saint-Jacques, Nathalie ^{[14
]}

De, Prithwish ^{[15
]}

McClure, Carol ^{[16
]}

Ramanakumar, Agnihotram V. ^{[17
]}

Stuart-Panko, Heather ^{[18
]}

Engholm, Gerda ^{[19
]}

Walsh, Paul M. ^{[20
]}

Jackson, Christopher ^{[21
]}

Vernon, Sally ^{[22
]}

Morgan, Eileen ^{[23
]}

Gavin, Anna ^{[23
]}

Morrison, David S. ^{[24
]}

Huws, Dyfed W. ^{[25
]}

Porter, Geoff ^{[26
]}

Butler, John ^{[27
]}

Bryant, Heather ^{[26
]}

Currow, David C. ^{[6
]}

Hiom, Sara ^{[28
]}

Parkin, D. Max ^{[29
]}

Sasieni, Peter ^{[30
]}

Lambert, Paul C. ^{[2
,3
]}

Moller, Bjorn ^{[4
]}

Soerjomataram, Isabelle ^{[1
]}

Bray, Freddie ^{[1
]}

机构：

[1] WHO, IARC, Canc Surveillance Sect, F-69008 Lyon, France

[2] Univ Leicester, Dept Hlth Sci, Biostat Res Grp, Leicester, Leics, England

[3] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden

[4] Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway

[5] More & Romsdal Hosp Trust, Dept Res & Innovat, Alesund, Norway

[6] Canc Inst NSW, Alexandria, NSW, Australia

[7] Canc Council Victoria, Victorian Canc Registry, Melbourne, Vic, Australia

[8] Hlth Networks Branch, Dept Hlth, WA Canc & Palliat Care Network Policy Unit, Perth, WA, Australia

[9] Alberta Hlth Serv, Canc Control Alberta, Calgary, AB, Canada

[10] BC Canc, Vancouver, BC, Canada

[11] CancerCare Manitoba, Populat Oncol, Winnipeg, MB, Canada

[12] Dr H Bliss Murphy Canc Ctr, Canc Care Program Eastern Hlth, Newfoundland Canc Registry, St John, NF, Canada

[13] New Brunswick Canc Network, Dept Hlth, Fredericton, NB, Canada

[14] Nova Scotia Hlth Author, Canc Care Program Registry & Analyt, Halifax, NS, Canada

[15] Canc Care Ontario, Surveillance & Canc Registry, Toronto, ON, Canada

[16] Prince Edward Isl Canc Registry, Charlottetown, PE, Canada

[17] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada

[18] Saskatchewan Canc Agcy, Regina, SK, Canada

[19] Danish Canc Soc, Copenhagen, Denmark

[20] Natl Canc Registry Ireland, Cork, Ireland

[21] Canc Soc New Zealand, Wellington, New Zealand

[22] Publ Hlth England, Natl Canc Registrat & Anal Serv, Cambridge, England

[23] Queens Univ Belfast, Northern Ireland Canc Registry, Belfast, Antrim, North Ireland

[24] Natl Hlth Serv Scotland, Informat Serv Div, Scottish Canc Registry, Edinburgh, Midlothian, Scotland

[25] Publ Hlth Wales, Welsh Canc Intelligence & Surveillance Unit, Cardiff, S Glam, Wales

[26] Canadian Partnership Canc, Toronto, ON, Canada

[27] Royal Marsden Hosp, London, England

[28] Canc Res UK, London, England

[29] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England

[30] Kings Coll London, Clin Trials Unit, London, England

来源：

LANCET ONCOLOGY | 2019年 / 20卷 / 11期

关键词：

BENCHMARKING PARTNERSHIP; DENMARK; AUSTRALIA; NORWAY; SWEDEN; CANADA; STAGE; REGISTRATION; DIAGNOSIS; UK;

D O I：

10.1016/S1470-2045(19)30456-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends. Methods In this longitudinal, population-based study, we collected patient-level data on 3.9 million patients with cancer from population-based cancer registries in 21 jurisdictions in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK) for seven sites of cancer (oesophagus, stomach, colon, rectum, pancreas, lung, and ovary) diagnosed between 1995 and 2014, and followed up until Dec 31, 2015. We calculated age-standardised net survival at 1 year and 5 years after diagnosis by site, age group, and period of diagnosis. We mapped changes in incidence and mortality to changes in survival to assess progress in cancer control. Findings In 19 eligible jurisdictions, 3 764 543 cases of cancer were eligible for inclusion in the study. In the 19 included jurisdictions, over 1995-2014, 1-year and 5-year net survival increased in each country across almost all cancer types, with, for example, 5-year rectal cancer survival increasing more than 13 percentage points in Denmark, Ireland, and the UK. For 2010-14, survival was generally higher in Australia, Canada, and Norway than in New Zealand, Denmark, Ireland, and the UK. Over the study period, larger survival improvements were observed for patients younger than 75 years at diagnosis than those aged 75 years and older, and notably for cancers with a poor prognosis (ie, oesophagus, stomach, pancreas, and lung). Progress in cancer control (ie, increased survival, decreased mortality and incidence) over the study period was evident for stomach, colon, lung (in males), and ovarian cancer. Interpretation The joint evaluation of trends in incidence, mortality, and survival indicated progress in four of the seven studied cancers. Cancer survival continues to increase across high-income countries; however, international disparities persist. While truly valid comparisons require differences in registration practice, classification, and coding to be minimal, stage of disease at diagnosis, timely access to effective treatment, and the extent of comorbidity are likely the main determinants of patient outcomes. Future studies are needed to assess the impact of these factors to further our understanding of international disparities in cancer survival.

引用

页码：1493 / 1505

页数：13

共 24 条

[1] Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].

Allemani, Claudia ;

Matsuda, Tomohiro ;

Di Carlo, Veronica ;

Harewood, Rhea ;

Matz, Melissa ;

Niksic, Maja ;

Bonaventure, Audrey ;

Valkov, Mikhail ;

Johnson, Christopher J. ;

Esteve, Jacques ;

Ogunbiyi, Olufemi J. ;

Azevedo e Silva, Gulnar ;

Chen, Wan-Qing ;

Eser, Sultan ;

Engholm, Gerda ;

Stiller, Charles A. ;

Monnereau, Alain ;

Woods, Ryan R. ;

Visser, Otto ;

Lim, Gek Hsiang ;

Aitken, Joanne ;

Weir, Hannah K. ;

Coleman, Michel P. .

LANCET, 2018, 391 (10125) :1023-1075

[2]

[Anonymous], SURVMARK CANC SURV H

[3] Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study [J].

Bertelsen, Claus Anders ;

Neuenschwander, Anders Ulrich ;

Jansen, Jens Erik ;

Wilhelmsen, Michael ;

Kirkegaard-Klitbo, Anders ;

Tenma, Jutaka Reilin ;

Bols, Birgitte ;

Ingeholm, Peter ;

Rasmussen, Leif Ahrenst ;

Jepsen, Lars Vedel ;

Iversen, Else Refsgaard ;

Kristensen, Bent ;

Gogenur, Ismail .

LANCET ONCOLOGY, 2015, 16 (02) :161-168

[4] Period versus cohort modeling of up-to-date cancer survival [J].

Brenner, Hermann ;

Hakulinen, Tinto .

INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (04) :898-904

[5] Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries [J].

Brenner, Hermann ;

Hakulinen, Timo .

INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (02) :432-437

[6] The International Cancer Benchmarking Partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom [J].

Butler, John ;

Foot, Catherine ;

Bomb, Martine ;

Hiom, Sara ;

Coleman, Michel ;

Bryant, Heather ;

Vedsted, Peter ;

Hanson, Jane ;

Richards, Mike .

HEALTH POLICY, 2013, 112 (1-2) :148-155

[7] Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data [J].

Coleman, M. P. ;

Forman, D. ;

Bryant, H. ;

Butler, J. ;

Rachet, B. ;

Maringe, C. ;

Nur, U. ;

Tracey, E. ;

Coory, M. ;

Hatcher, J. ;

McGahan, C. E. ;

Turner, D. ;

Marrett, L. ;

Gjerstorff, M. L. ;

Johannesen, T. B. ;

Adolfsson, J. ;

Lambe, M. ;

Lawrence, G. ;

Meechan, D. ;

Morris, E. J. ;

Middleton, R. ;

Steward, J. ;

Richards, M. A. .

LANCET, 2011, 377 (9760) :127-138

[8] Standard cancer patient population for age standardising survival ratios [J].

Corazziari, I ;

Quinn, M ;

Capocaccia, R .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) :2307-2316

[9] Estimating net survival using a life-table approach [J].

Coviello, Enzo ;

Dickman, Paul W. ;

Seppa, Karri ;

Pokhrel, Arun .

STATA JOURNAL, 2015, 15 (01) :173-185

[10] Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study [J].

De Angelis, Roberta ;

Sant, Milena ;

Coleman, Michel P. ;

Francisci, Silvia ;

Baili, Paolo ;

Pierannunzio, Daniela ;

Trama, Annalisa ;

Visser, Otto ;

Brenner, Hermann ;

Ardanaz, Eva ;

Bielska-Lasota, Magdalena ;

Engholm, Gerda ;

Nennecke, Alice ;

Siesling, Sabine ;

Berrino, Franco ;

Capocaccia, Riccardo .

LANCET ONCOLOGY, 2014, 15 (01) :23-34

← 1 2 3 →